Market closed

Inari Medical/$NARI

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Inari Medical

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Ticker

$NARI
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Irvine, United States

Employees

1,300
Website
www.inarimedical.com

Inari Medical Metrics

BasicAdvanced
$4.6B
-
-$1.35
0.97
-

$4.6B

0.97

$79.69

$36.73

3.1M

1.77

1.317

7.164

7.527

-106.01%

-3.21%

-17.72%

8.013

10.66

59.74

2,911.88

22.41%

2,628.31%

33.33%

68.38%

What the Analysts think about Inari Medical

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Inari Medical stock.

Inari Medical Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Inari Medical Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Inari Medical News

AllArticlesVideos
Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect

Accesswire·3 days ago
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI

INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI

Business Wire·1 week ago
Medical Stock Surges to Multi-Year Highs on Acquisition News

Medical Stock Surges to Multi-Year Highs on Acquisition News

Schaeffers Research·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NARI

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Inari Medical stock?

Inari Medical (NARI) has a market cap of $4.6B as of January 15, 2025.

What is the P/E ratio for Inari Medical stock?

The price to earnings (P/E) ratio for Inari Medical (NARI) stock is 0 as of January 15, 2025.

Does Inari Medical stock pay dividends?

No, Inari Medical (NARI) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Inari Medical dividend payment date?

Inari Medical (NARI) stock does not pay dividends to its shareholders.

What is the beta indicator for Inari Medical?

Inari Medical (NARI) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.